User:Allie Pointer/Pointer Sandbox 1: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 15: | Line 15: | ||
If you include reference in writing it is going to double show up in reference list | If you include reference in writing it is going to double show up in reference list | ||
Reference shows up have to be above the ( | Reference shows up have to be above the (arrow references arrow) | ||
== Function == | == Function == | ||
Revision as of 19:33, 4 March 2020
Interleukin-12
| ||||||||||||
References
- ↑ Lasek W, Zagozdzon R, Jakobisiak M. Interleukin 12: still a promising candidate for tumor immunotherapy? Cancer Immunol Immunother. 2014 May;63(5):419-35. doi: 10.1007/s00262-014-1523-1., Epub 2014 Feb 11. PMID:24514955 doi:https://dx.doi.org/10.1007/s00262-014-1523-1
- ↑ Yoon C, Johnston SC, Tang J, Stahl M, Tobin JF, Somers WS. Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12. EMBO J. 2000 Jul 17;19(14):3530-41. PMID:10899108 doi:https://dx.doi.org/10.1093/emboj/19.14.3530
